Jean-Luc Devleeschauwer is the founder of SHI, a boutique consulting Company dedicated to help companies develop their business in the Healthcare field and supporting Countries to develop their Cancer Plans or network of Oncology Treatment Facilities..
Portfolio growth, M&A, procurement, distribution, channel management and new technologies scouting.
Design and implementation of Cancer Plans or Oncology Treatment Facilities
are the core of SHI activity, leveraging Jean-Luc's multi years' experience and impressive network in America, Europe, Russia/CIS, Middle East, Africa, India, Asia.
Jean-Luc was previously President Europe, Middle East, Africa, India and CIS for Varian Oncology Systems after having occupied the same role in Asia Pacific
Prior to joining Varian, Jean-Luc was Vice President and General Manager, International, for nanoString, operating in the field of Genetic Testing with focus on a Breast Cancer signature.
Jean-Luc has occupied for the
last 27 years executive leadership positions
with major global companies including Novartis Vaccines and Diagnostics, Siemens Healthcare Diagnostic and Dade Behring. His wealth of experience stems across the field of medical devices, diagnostic, pharma, blood banking, oncology, genetic testing and radiotherapy.
He has extensive multi-cultural management experience in Europe, USA and Asia, managing large operations, creating new structures or integrating organizations.